Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-16-010897
Filing Date
2016-02-16
Accepted
2016-02-16 12:02:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7043589_13-g.htm SC 13G 155430
  Complete submission text file 0000919574-16-010897.txt   157268
Mailing Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019 212-370-0303
SCOPIA CAPITAL MANAGEMENT LP (Filed by) CIK: 0001279150 (see all company filings)

EIN.: 300711986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Subject) CIK: 0001516479 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87828 | Film No.: 161425164
SIC: 2834 Pharmaceutical Preparations